News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

New and experimental hepatitis C treatment news

Show

From To
New and experimental hepatitis C treatment
Investigational drug for hepatitis C boceprevir achieved significantly higher sustained virologic response rates compared to control

Merck reported today that final results from two pivotal Phase III studies of boceprevir, its investigational oral hepatitis C protease inhibitor.

Published
31 October 2010
From
Digital Journal
New and experimental hepatitis C treatment
Vertex releases results of phase III study of telaprevir in hepatitis C

Vertex Pharmaceuticals today announced results from the Phase 3 ILLUMINATE study, which was designed to evaluate whether there was any benefit to extending therapy from 24 to 48 weeks in people whose hepatitis C virus (HCV) was undetectable at weeks 4 and 12 of treatment (extended rapid viral response or eRVR).

Published
10 August 2010
From
Business Wire
Hepatitis C treatment
Combinations and conundrums: the challenges of hepatitis C treatment

A multiplicity of new drugs for hepatitis C are being researched. As Gus Cairns discovers, though, they face an elusive enemy, a shape-shifter of a virus that won’t

Published
01 July 2009
From
HIV treatment update
Hepatitis C transmission and prevention
Hepatitis C vaccine hope

A vaccine against the hepatitis C virus (HCV) may be on the market by 2010, a leading hepatitis C researcher told the Eleventh International Symposium

Published
11 April 2003
By
Megan Nicholson
New and experimental hepatitis C treatment
Hepatitis C drug pipeline growing, `progress accelerating`

A number of new antivirals for the treatment of hepatitis C are in the pipeline, according to new research presented at the Eleventh International Symposium

Published
11 April 2003
By
Megan Nicholson
← Prev1...6162636465Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.